Concepedia

Andrea Harzstark

AH

Statistics

Publications

37

Citations

4.9K

H-Index

24

Active since

2007

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Andrea Harzstark is an author at University of California, San Francisco specializing in oncology, medicine, and pharmacology.

Publications per year

2007–2022

37

Publications

37

Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1- <sup>13</sup> C]Pyruvate

Sarah J. Nelson, John Kurhanewicz, Daniel B. Vigneron et al. · Science Translational Medicine · 2013 · 1.3K citations · Full text

Medicine, Oncology, Radiology +16

Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study

Susan F. Slovin, Celestia S. Higano, Omid Hamid et al. · Annals of Oncology · 2013 · 550 citations · Full text

Medicine, Oncology, Pharmacology +14

Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

Ana M. Aparicio, Andrea Harzstark, Paul G. Corn et al. · Clinical Cancer Research · 2013 · 466 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma

Toni K. Choueiri, Ulka N. Vaishampayan, Jonathan E. Rosenberg et al. · Journal of Clinical Oncology · 2012 · 458 citations · Full text

Medicine, Oncology, Pharmacology +17

Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial

David C. Smith, Matthew R. Smith, Christopher J. Sweeney et al. · Journal of Clinical Oncology · 2012 · 443 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

1–5 of 37